These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3252246)

  • 1. Ethanol withdrawal alters apomorphine-induced motility.
    Gonzalez LP; Czachura JF
    Pharmacol Biochem Behav; 1988 Sep; 31(1):163-8. PubMed ID: 3252246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine-induced hypothermia increases during ethanol withdrawal.
    Gonzalez LP; Colbern DL; Czachura JF
    Alcohol; 1988; 5(2):107-9. PubMed ID: 3395457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single and long-term metoclopramide administration on open field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Eur J Pharmacol; 1988 May; 149(3):323-9. PubMed ID: 3409956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
    Waddington JL; Gamble SJ
    Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced behavioral responses to intranigral muscimol following chronic ethanol.
    Gonzalez LP; Czachura JF
    Physiol Behav; 1989 Sep; 46(3):473-7. PubMed ID: 2623072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural correlates of modified dopaminergic/anticholinergic responses following chronic treatment with neuroleptic agents of differing activity spectra.
    Costall B; Naylor RJ; Owen RT
    Eur J Pharmacol; 1978 Mar; 48(1):29-36. PubMed ID: 25189
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of apomorphine administration on locomotor activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1983; 14(5):545-7. PubMed ID: 6685669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Physiol Behav; 1991 Oct; 50(4):825-30. PubMed ID: 1775558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopamine neurotransmission in ethanol dependence development and ethanol withdrawal in rats.
    Samochowiec J; Kleinrok Z; Horodnicki J
    Pharmazie; 1995 Dec; 50(12):815-8. PubMed ID: 8584559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic supersensitivity after long-term bromopride treatment.
    Felicio LF; Nasello AG; Palermo-Neto J
    Physiol Behav; 1987; 41(5):433-7. PubMed ID: 3432396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lateralizing effects of apomorphine on taxis, postural support and rotation in rats.
    Pisa M; Szechtman H
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):525-31. PubMed ID: 4089183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological effects of low and high doses of apomorphine during ontogeny.
    Shalaby IA; Spear LP
    Eur J Pharmacol; 1980 Oct; 67(4):451-9. PubMed ID: 7192634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.